Tag: for

Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors

– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and…

GlobeNews Wire

Cipla Health welcomes FSSAI’s new labelling rules for ‘ORS’, reinforces Prolyte ORS as the #AsliORS

MUMBAI, India, Oct. 24, 2025 /PRNewswire/ -- ProlyteORS, the flagship brand of…

Bybit Enhances Capital Mobility for VIP and Institutional Traders with Expanded Withdrawal Limits

DUBAI, UAE, Oct. 24, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…

Startek honored with the AAA DI-verse Certification for disability inclusion excellence

Recognition marks Startek's commitment to building an inclusive and accessible workplace for all…

GAC Supplies Official Fleet and 24/7 Support for the 15th National Games in Hong Kong and Macao

HONG KONG and MACAO, Oct. 24, 2025 /PRNewswire/ -- The official vehicle handover…

ArisGlobal Receives Frost & Sullivan’s 2025 Global Intelligent MedDRA Coding New Product Innovation Recognition for AI Leadership and Customer Impact

ArisGlobal is honored for its technological breakthrough in intelligent MedDRA coding that…